YOLFTbeta
PharmaCyte Biotech Inc

PharmaCyte Biotech Inc

PMCB · NASDAQ · Healthcare / Biotechnology

6.68USD+6.28 (+1561.69%)

Price History

Full chart

Market Stats

Previous Close0.402
Open8.17
Day Range6.50 – 8.17
52-Week Range0.3339 – 1.51
Volume126.43K
Market Cap4.73M
P/E (TTM)0.00
Forward P/E7.02
EPS-2.08
Dividend Yield0.00%
Beta0.66
50-Day Avg0.529
200-Day Avg0.7092

About

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Joshua N. Silverman
  • Employees2
  • Headquarters3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169, USA
  • Websitehttps://pharmacyte.com

Leadership

  • Mr. Joshua N. SilvermanCEO. President & Executive Chairman · b. 1970
  • Mr. Carlos A. Trujillo CPAChief Financial Officer · b. 1958
  • Dr. Jose L. Iglesias M.D.Consulting Chief Medical Officer · b. 1957
  • Dr. Hans-Peter Hammes M.D.Member of Medical & Scientific Advisory Board and Consultant

Financials

Income Statement

Currency: USD2002-04-302003-04-302004-04-302005-04-302006-04-302007-04-302008-04-302009-04-302010-04-302011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Revenue--2.38K86.37K537.04K1.17M1.19M653.13K262.93K126.00K66.56K12.16K0000000000000
Growth (%)---+3524.59%+521.76%+117.80%+1.74%-45.11%-59.74%-52.08%-47.17%-81.73%-100.00%------------
Cost of Revenue--78041.40K488171.01K266.20K427.41K228.66K32.10K19.38K9.62K00000--------
Gross Profit--1.60K44.97K537.04K998.65K923.75K225.72K34.27K93.89K47.17K2.54K00000--------
Gross Margin--67.27%52.07%100.00%85.38%77.63%34.56%13.03%74.52%70.88%20.89%-------------
Operating Expense--1.72M1.77M7.87M4.61M4.67M6.40M2.14M482.25K2.00M1.69M18.98M13.70M6.07M4.44M6.98M--------
Operating Income-29.85K-32.13K-1.72M-1.72M-7.34M-3.61M-3.75M-6.18M-2.11M-388.36K-1.95M-1.68M-18.98M-13.70M-6.07M-4.44M-6.98M-4.10M-3.83M-3.62M-4.39M-6.46M-8.52M-4.38M-6.85M
Operating Margin---72213.26%-1994.19%-1365.85%-308.42%-315.07%-945.74%-802.09%-308.23%-2928.55%-13851.65%-------------
EBITDA-29.85K-32.13K-1.72M-1.72M-7.33M-3.61M-3.74M-6.15M-5.58M-347.67K-1.63M-1.68M-27.23M-9.92M-6.07M-4.44M-6.83M-4.10M-3.83M-3.55M-4.24M-6.46M-6.52M-4.38M-5.30M
EBITDA Margin---72213.26%-1994.19%-1365.76%-308.31%-314.54%-941.35%-2123.92%-275.94%-2454.11%-13851.65%-------------
Net Income-29.85K-32.13K-1.72M-4.28M-9.39M-3.61M-3.79M-7.04M-5.99M-1.40M-1.90M-1.60M-27.25M-10.86M-6.06M-4.44M-6.83M-4.07M-3.83M-3.55M-4.24M-4.32M333.76K30.66M-19.42M
Net Income Margin---72375.79%-4951.60%-1747.61%-309.00%-318.66%-1078.31%-2278.89%-1109.32%-2853.62%-13142.29%-------------
R&D--1.41M1.11M119.01K133.84K412.88K473.51K492.46K9.21K--323.53.48M1.41M1.18M2.00M460.05K301.22K916.25K690.94K468.54K407.43K438.42K391.30K
R&D as % of Total Revenue--59106.17%1282.91%22.16%11.44%34.70%72.50%187.30%7.31%---------------
Interest Expense000000036.47K292.56K171.66K241.25K154.42K21.05K4.94K1.19K1.54K004533.05K5090---
Interest Expense % of Total Revenue--0.00%0.00%0.00%0.00%0.00%5.58%111.27%136.24%362.46%1269.87%-------------

Balance Sheet

Currency: USD2002-04-302003-04-302004-04-302005-04-302006-04-302007-04-302008-04-302009-04-302010-04-302011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Assets--175.71K336.36K5.14M4.41M7.62M6.04M1.20M1.24M2.09M2.88M9.32M7.95M7.16M8.67M6.41M5.78M6.17M7.40M90.62M73.28M59.90M55.17M46.75M
Total Liabilities7.86K2.52K329.13K1.63M723.89K118.81K180.56K2.92M3.15M3.97M3.79M3.80M373.67K2.01M637.64K580.25K644.17K742.85K1.08M724.78K704.37K586.58K20.39M3.28M11.77M
Total Equity-7.86K-2.52K-153.43K-1.30M4.41M4.29M7.44M3.12M-1.95M-2.73M-1.70M-921.46K8.94M5.94M6.52M8.09M5.77M5.04M5.09M6.68M89.92M72.69M39.51M51.89M33.29M
Cash--83.60K38.34K1.07M1.11M1.51M603.73K71657.20K15.72K199.30K3.62M2.70M1.92M3.46M1.06M515.25K894.86K2.20M85.40M68.04M50.18M15.17M18.60M
Total Debt--325.00K1.28M507.98K--2.48M2.38M2.37M2.09M420.00K143.86-----75.20K50.80K-----
Net Debt--241.40K1.24M-560.97K-1.11M-1.51M1.87M2.38M2.31M2.08M220.70K-3.62M-2.70M-1.92M-3.46M-1.06M-515.25K-819.66K-2.20M-85.40M-68.04M-50.18M-15.17M-18.60M

Cash Flow

Currency: USD2002-04-302003-04-302004-04-302005-04-302006-04-302007-04-302008-04-302009-04-302010-04-302011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow-21.99K-37.46K-221.03K-2.80M-1.07M-351.60K-1.19M-1.19M-974.06K-225.23K-259.29K-390.43K-1.56M-4.56M-4.35M-3.34M-5.08M-2.88M-2.34M-3.33M-4.12M-3.79M-2.15M-2.98M-5.15M
Investing Cash Flow---45.00K-230.58K157.78K-694.00K-9.57K-13.67K75.00K74.97K-871.73K-646.75K-3.55M----------5.00M-7.00M2.00M
Financing Cash Flow21.99K37.46K349.63K2.98M1.95M1.09M1.61M289.23K296.08K281.72K1.09M1.22M8.53M3.64M3.57M4.88M2.68M2.34M2.73M4.64M87.31M-13.56M-10.71M-25.03M6.58M
Capital Expenditure0045.00K70.55K7.24K696.52K21.05K5.08K05.08K003.50M000000000340
Free Cash Flow-21.99K-37.46K-266.03K-2.87M-1.08M-1.05M-1.21M-1.19M-974.06K-225.23K-259.29K-390.43K-5.06M-4.56M-4.35M-3.34M-5.08M-2.88M-2.34M-3.33M-4.12M-3.79M-2.15M-2.98M-5.15M
Dividends Paid---------20.12K------------22.46M1.13M246.00K
FCF to OCF100.00%100.00%120.36%102.52%100.68%298.10%101.77%100.43%100.00%100.00%100.00%100.00%323.99%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF----------8.93%-------------1043.81%-37.93%-4.77%

Earnings

Report DateJul 31, 2004Oct 31, 2004Jan 31, 2005Apr 30, 2005Jul 31, 2005Oct 31, 2005Jan 31, 2006Apr 30, 2006Jul 31, 2006Oct 31, 2006Jan 31, 2007Apr 30, 2007Jul 31, 2007Oct 31, 2007Jan 31, 2008Apr 30, 2008Jul 31, 2008Oct 31, 2008Jan 31, 2009Apr 30, 2009Jul 31, 2009Oct 31, 2009Jan 31, 2010Apr 30, 2010Jul 31, 2010Jan 31, 2011Apr 30, 2011Jul 31, 2011Oct 31, 2011Jan 31, 2012Apr 30, 2012Jul 31, 2012Oct 31, 2012Jan 31, 2013Apr 30, 2013Jul 31, 2013Oct 31, 2013Jan 31, 2014Apr 30, 2014Jul 31, 2014Oct 31, 2014Jan 31, 2015Apr 30, 2015Jul 29, 2015Aug 25, 2015Jan 31, 2016Apr 30, 2016Jul 28, 2016Sep 7, 2016Dec 2, 2016Mar 13, 2017Jul 27, 2017Sep 13, 2017Dec 14, 2017Mar 19, 2018Jul 20, 2018Sep 12, 2018Dec 14, 2018Mar 14, 2019Jul 3, 2019Sep 13, 2019Dec 23, 2019Mar 13, 2020Jul 1, 2020Sep 11, 2020Dec 11, 2020Mar 12, 2021Jun 30, 2021Sep 14, 2021Dec 14, 2021Mar 15, 2022Jul 28, 2022Sep 14, 2022Dec 14, 2022Mar 16, 2023Jul 31, 2023Sep 18, 2023Dec 15, 2023Mar 18, 2024Jul 29, 2024Aug 13, 2024Dec 13, 2024Mar 17, 2025Jul 2, 2025Sep 15, 2025Dec 31, 2025Mar 17, 2026Jul 29, 2026Sep 14, 2026
EPS Estimate--------------------------------------------15.00-15.00------------------------0.64-0.07-0.05-0.04-0.07-0.08-0.08-0.09-0.07-0.08-0.07----0.000.000.000.00--
EPS Actual-5.67-19.75-7.02-30.00-19.15-24.479.07-45.00-12.62-5.17-7.31-6.62-8.26-8.12-19.50-9.52-3.89-3.27-6.75-27.73-4.29-2.47-9.58-11.55-0.58-0.00-0.00-2.80-1.75-1.09-1.97-1.83-1.34-1.27-1.06-13.41-15.68-1.15-41.26-3.39-8.67-3.14-5.96-15.00-3.29-3.55-2.19-1.96-1.72-2.24-8.76-2.74-2.80-3.12-1.94-1.74-1.44-0.90-1.49-1.41-1.21-0.95-0.72-0.79-0.62-0.49-0.61-0.64-0.64-0.06-0.04-0.06-0.07-0.09-0.04-0.01-0.28-0.26-0.07-0.321.90-0.39-0.441.58-1.23-1.24-0.17-0.01-0.54
Surprise-------------------------------------------0.00%78.06%-----------------------0.00%14.29%20.00%-50.00%0.00%-14.25%49.75%91.67%-297.14%-222.00%0.00%----------
Timing--------------------------------------------Pre-market---Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market------

Key Statistics & Ratios

Market Cap4.73M
Enterprise Value-24.02M
Trailing P/E0.00
Forward P/E7.02
PEG Ratio0.00
Price / Sales12904.41
Price / Book0.16
EPS-2.08
Book Value2.60
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-43.99%
Return on Assets-8.35%
Shares Outstanding10.74M
Shares Float10.07M
Beta0.66
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
7.11%
Insiders
5.74%
Retail / Other
87.15%

Top Institutional Holders

  • Citadel Advisors Llc
    283.38K2.64%
  • Geode Capital Management, LLC
    195.66K1.82%
  • Renaissance Technologies Corp
    56.50K0.53%
  • XTX Topco Ltd
    52.36K0.49%
  • Vanguard Capital Management, LLC
    51.47K0.48%
  • Virtu Financial LLC
    37.53K0.35%
  • Northern Trust Corp
    35.60K0.33%
  • Schonfeld Strategic Advisors LLC
    27.01K0.25%
  • HRT FINANCIAL LLC
    24.74K0.23%
  • Vanguard Fiduciary Trust Co
    23.45K0.22%
  • EQUITEC PROPRIETARY MARKETS, LLC
    22.23K0.21%
  • Commonwealth Equity Services, LLC
    20.25K0.19%
  • SIMPLEX TRADING, LLC
    19.94K0.19%
  • TWO SIGMA SECURITIES, LLC
    16.36K0.15%
  • Jane Street Group LLC
    11.53K0.11%
  • Tower Research Capital LLC
    4.89K0.05%

Top Fund Holders

  • Fidelity Extended Market Index
    58.55K0.55%
  • Fidelity Nasdaq Composite Index
    17.45K0.16%
  • Fidelity Total Market Index
    15.26K0.14%
  • Fidelity Series Total Market Index
    12.90K0.12%

Stock Splits

  • Nov 13, 20261:19
  • Jul 12, 20211:1500
  • Dec 8, 2003959692:319897